
Age: 68
male
Colm Joseph Feore OC (/ˈkɒləm ˈfjɔːr/; born August 22, 1958) is a Canadian actor. A 15-year veteran of the Stratford Festival, he is known for his Gemini-winning turn as Prime Minister Pierre Trudeau in the CBC miniseries Trudeau (2002), his portrayal of Glenn Gould in Thirty Two Short Films About Glenn Gould (1993), and for playing Detective Martin Ward in Bon Cop, Bad Cop (2006) and its sequel Bon Cop, Bad Cop 2 (2017). His other roles include Martin Harrison in Chicago (2002), Lord Marshal Zhylaw in The Chronicles of Riddick (2004), First Gentleman Henry Taylor on 24 (2009), Cardinal Della Rovere on The Borgias (2011–2013), Laufey in Thor (2011), General Ted Brockhart on House of Cards (2016–2017), Declan Gallard on 21 Thunder (2017), Wernher von Braun in For All Mankind (2019), and Sir Reginald Hargreeves on The Umbrella Academy (2019–present). Feore is also a Prix Iris and Screen Actors Guild Award winner and a Genie Award nominee.

Colm Feore

Donald Menken
for Donald Menken in The Amazing Spider-Man 2
Suggested by moonlightbeast495

We've always known that Spider-Man's most important conflict has been within himself: the struggle between the ordinary obligations of Peter Parker and the extraordinary responsibilities of Spider-Man. But in The Amazing Spider-Man 2, Peter Parker finds that his greatest battle is about to begin. It's great to be Spider-Man. For Peter Parker, there's no feeling quite like swinging between skyscrapers, embracing being the hero, and spending time with Gwen. But being Spider-Man comes at a price: only Spider-Man can protect his fellow New Yorkers but after Jason Philip Macendale Jr./Hobgoblin (Jacob L. I. Hodapp) gets fired from Donald Menken from his Hobgoblin project he decides to work with Electro (Alex Pettyfer) from the formidable villains that threaten the city Peter must confront a foe far more powerful than he. And as his old friend, Harry Osborn, returns, Peter comes to realize Aleksei Sytsevich/Rhino (Hafþór Júlíus Björnsson) that all of his enemies have one thing in common: Oscorp.